Fundraising FoxBiolumen
San Francisco, US · Founded 2019 · Delaware corporation · 2 known investors
Find your way into Biolumen
Sign up to see every warm intro you have to Biolumen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biolumen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biolumen is a biotech company focused on bioengineering for wellness, founded by a serial entrepreneur with expertise in biopolymers. The company appears to be developing food and beverage-related products leveraging bioengineering innovations.
Founders & leadership
PC
Paolo CostaChief Executive OfficerCosta began his career in polymer laboratories at ItalPlastic and as lab chief for quality control at Soplastic Faaca before founding a series of companies, including Vispaav, Stile Italiano, Teratekne and Primigenia. From 2015 to 2018 he served as founder, president and CEO of Slendine AG, and he has led BioLumen as chief executive officer since 2020.
GP
Gabriel PaulinoCo-Founder & Chief Executive Officer2019–2020Gabriel Paulino is President and CEO of Biolumen, a biotech company developing bioengineered products for wellness applications in food, beverage, and related sectors. He has background in agriculture, biochemistry, and business development across health tech and biotech industries.
SP
Stefan PinterTreasurer
Investors · 2
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2019
▶$250KraisedNov 2019 · 1 investors · OtherRule 506(b)
▶$250KraisedNov 2019 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Paolo CostaExecutive Officer, Director, Promoter
- Gabriel PaulinoExecutive Officer, Director, Promoter
- Stefan PinterExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
LumenLumen develops orally delivered antibody drugs using engineered spirulina, a patented biologic platform that reduces manufacturing costs and timelines compared to conventional biologics. The company serves biopharma customers seeking alternatives to traditional drug manufacturing.
MorelumenMore Lumen produces Peaches & Cream, a dairy-free sparkling protein drink designed for consumers seeking clean nutrition without heavy texture or artificial ingredients. The product targets health-conscious individuals looking for convenient protein supplementation that fits into daily routines.
SOSVSOSV is a venture capital firm that provides pre-seed funding (up to $550,000) to founders in deep technology sectors including life sciences, robotics, industrial automation, energy transition, and medical technology. The firm operates accelerator programs in New York City, San Francisco, and Newark, NJ, and does not invest in enterprise software, fintech, blockchain, crypto, cybersecurity, or ecommerce.
EquityZenEquityZen operates an online marketplace that gives accredited individual investors access to shares in late-stage private companies through secondary market transactions. Now part of Morgan Stanley, the platform provides private market data, offering documents, and guided investment processes for buying and selling pre-IPO equity.
Companies working in the same space as Biolumen.
Frequently asked questions
- What does Biolumen do?
- Biolumen is a biotech company focused on bioengineering for wellness, founded by a serial entrepreneur with expertise in biopolymers. The company appears to be developing food and beverage-related products leveraging bioengineering innovations.
- Who are Biolumen's investors?
- Biolumen's investors include Embryo Ventures, SOSV.
- How much funding has Biolumen raised?
- Biolumen has disclosed $250K raised across 1 round.
- Where is Biolumen headquartered?
- Biolumen is headquartered in San Francisco, US.